Date published: 2025-9-11

021-6093-6350

SCBT Portrait Logo
Seach Input

μ-protocadherin 抑制因子

Cadherin-dependent calcium-dependent cell adhesion is a crucial process in maintaining tissue structure and integrity in multicellular organisms. Cadherins, a class of transmembrane proteins, mediate this adhesion by forming homophilic interactions between adjacent cells in a calcium-dependent manner. The presence of calcium ions is essential for the structural stability of cadherins, as they promote the proper conformation for binding. These adhesion complexes are linked to the actin cytoskeleton via catenins, facilitating the transmission of intracellular signals that regulate cell behavior, morphology, and differentiation. The specificity and strength of cadherin-mediated adhesion play a vital role in processes like embryonic development, wound healing, and maintaining epithelial and endothelial barriers.

Targeting cadherins for disruption or inhibition involves intervening in the cadherin-mediated cell adhesion process, which can have significant implications in understanding cellular dynamics and disease processes. Small molecule inhibitors, peptides, or antibodies that specifically bind to cadherins can directly disrupt their adhesion function. Alternatively, modulation of the calcium levels in the cellular environment can indirectly impact cadherin stability and adhesion, as cadherins require calcium ions for their structural integrity and function. Targeting the post-translational modifications of cadherins, such as glycosylation, or interfering with the linkage between cadherins and catenins, can also disrupt cadherin-mediated adhesion. This targeted disruption of cadherins has been a focus in studies related to cancer metastasis, tissue development, and understanding the mechanisms of cell-cell interaction.

関連項目

Items 1 to 10 of 12 total

展示:

产品名称CAS #产品编号数量价格应用排名

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

这种胞苷类似物可导致Mu-protocadherin基因启动子的DNA脱甲基化,最终降低转录抑制因子的结合亲和力。

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

作为一种组蛋白去乙酰化酶抑制剂,它可能会导致Mu-protocadherin基因附近的组蛋白过度乙酰化,从而导致染色质构象闭合和转录减少。

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

这种化合物通过插入DNA,可能会阻止RNA聚合酶在Mu-protocadherin基因上的进展,从而导致mRNA合成减少。

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$214.00
$316.00
$418.00
7
(1)

这种DNA甲基转移酶抑制剂可以降低Mu-protocadherin启动子上的甲基化水平,从而减少转录的启动。

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

通过抑制mTOR信号通路,可能会导致Mu-protocadherin的下调,而mTOR信号通路对于各种基因的转录至关重要。

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

可能与拓扑异构酶II结合,导致Mu-protocadherin基因位点的DNA断裂,从而降低其表达。

(±)-JQ1

1268524-69-1sc-472932
sc-472932A
5 mg
25 mg
$226.00
$846.00
1
(0)

这种溴结构域抑制剂可以抑制转录机制对Mu-protocadherin基因位点的招募,从而降低其表达。

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$30.00
$46.00
$82.00
$218.00
18
(3)

这种化学物质可能会导致Mu-protocadherin基因组中组蛋白的超乙酰化,从而形成更紧密的染色质结构并降低转录活性。

Methotrexate

59-05-2sc-3507
sc-3507A
100 mg
500 mg
$92.00
$209.00
33
(5)

通过抑制二氢叶酸还原酶,它可以降低胸腺嘧啶核苷的合成,从而减少Mu-protocadherin基因表达所需的DNA复制。

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

通过阻碍与基因调控元件结合的维甲酸受体的转录活性,可能下调Mu-protocadherin。